Final answer:
The goal for functional treatment of HD is to manage symptoms and improve life quality; however, treatment efficacy is hampered by untreated traumas. Genome mapping investments aim to target genetically based cancers more effectively. The presence of a capsule in bacteria denotes a higher difficulty in treating infections due to immune system evasion.
Step-by-step explanation:
The goal for functional approaches for the treatment of Huntington's Disease (HD) is to help manage symptoms and improve quality of life by setting and meeting mobility goals. This is challenging due to barriers such as untreated trauma, including childhood trauma, prostitution, and intergenerational family dysfunction, which can complicate the effectiveness of these treatments.
Regarding efforts in genome mapping, scientists are investing significant resources into genome mapping applications because a genetic map of the human genome could lead to breakthroughs in understanding and treating genetically based cancers. By identifying specific genetic mutations that contribute to cancer, targeted therapies can be developed to combat these diseases more effectively.
In clinical settings, ineffective treatments can result from various factors, such as resistance or a failure to target the cause of the disease. The presence of a capsule is clinically important because it can protect bacteria from the host's immune system, making infections harder to treat.